These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32072591)

  • 1. Estimating the Impact of Food and Drug Administration's Unapproved Drug Initiative on Drug Prices and Sales.
    Sharma D; Schumock GT; Saffore CD; Albert Edwards S; Walton SM
    Ther Innov Regul Sci; 2020 Mar; 54(2):424-430. PubMed ID: 32072591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FDA Unapproved Drugs Initiative: An Observational Study of the Consequences for Drug Prices and Shortages in the United States.
    Gupta R; Dhruva SS; Fox ER; Ross JS
    J Manag Care Spec Pharm; 2017 Oct; 23(10):1066-1076. PubMed ID: 28944731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threats to global antimicrobial resistance control: Centrally approved and unapproved antibiotic formulations sold in India.
    McGettigan P; Roderick P; Kadam A; Pollock A
    Br J Clin Pharmacol; 2019 Jan; 85(1):59-70. PubMed ID: 29397576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What Commissioner Gottlieb's FDA Is Doing to Lower Prescription Drug Prices and Steps Congress Can Take to Help.
    Waxman H; Corr B; Martin K; Duong S
    Issue Brief (Commonw Fund); 2018 Apr; 2018():1-10. PubMed ID: 29992802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
    Ostroff C; Lee CE; McMeekin J
    Chest; 2011 Aug; 140(2):295-300. PubMed ID: 21813527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies.
    Tay-Teo K; Ilbawi A; Hill SR
    JAMA Netw Open; 2019 Jan; 2(1):e186875. PubMed ID: 30644967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History and Current Trends in the Electronic Cigarette Retail Marketplace in the United States: 2010-2016.
    Cantrell J; Huang J; Greenberg M; Willett J; Hair E; Vallone D
    Nicotine Tob Res; 2020 Apr; 22(5):843-847. PubMed ID: 30312465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent Portfolios Protecting 10 Top-Selling Prescription Drugs.
    Horrow C; Gabriele SME; Tu SS; Sarpatwari A; Kesselheim AS
    JAMA Intern Med; 2024 Jul; 184(7):810-817. PubMed ID: 38739386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unapproved drugs--the drug information pharmacists' perspective.
    Giouroukakis M; Dryer M
    J Pharm Pract; 2013 Apr; 26(2):112-9. PubMed ID: 23459285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors that have an Impact on Abbreviated New Drug Application (ANDA) Submissions.
    Wittayanukorn S; Rosenberg M; Schick A; Hu M; Wang Z; Babiskin A; Lionberger R; Zhao L
    Ther Innov Regul Sci; 2020 Nov; 54(6):1372-1381. PubMed ID: 32495310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA policy on unapproved drug products: past, present, and future.
    Chhabra R; Kremzner ME; Kiliany BJ
    Ann Pharmacother; 2005; 39(7-8):1260-4. PubMed ID: 15956239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies.
    Kakani P; Chernew M; Chandra A
    J Health Polit Policy Law; 2022 Dec; 47(6):629-648. PubMed ID: 35867538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs.
    McGettigan P; Roderick P; Mahajan R; Kadam A; Pollock AM
    PLoS Med; 2015 May; 12(5):e1001826; discussion e1001826. PubMed ID: 25965416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending the US Food and Drug Administration's Postmarket Authorities.
    Fernandez Lynch H; Sachs RE; Lee S; Herder M; Ross JS; Ramachandran R
    JAMA Health Forum; 2023 Jun; 4(6):e231313. PubMed ID: 37294583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986-2019.
    Olsen A; Beall RF; Knox RP; Tu SS; Kesselheim AS; Feldman WB
    PLoS Med; 2023 Nov; 20(11):e1004309. PubMed ID: 37971985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FDA takes action against unapproved drugs.
    Meadows M
    FDA Consum; 2007; 41(1):34-5. PubMed ID: 17342837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in manufacturer prices of brand name prescription drugs used by older Americans--first quarter 2004 update.
    Gross DJ; Schondelmeyer SW; Raetzman SO
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2004 Jun; (IB69):1-12, 1-2. PubMed ID: 15368653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicaid and Accelerated Approval: Spending on Drugs with and without Proven Clinical Benefits.
    Sachs RE; Jazowski SA; Gavulic KA; Donohue JM; Dusetzina SB
    J Health Polit Policy Law; 2022 Dec; 47(6):673-690. PubMed ID: 35867545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet.
    Van Wagoner RM; Eichner A; Bhasin S; Deuster PA; Eichner D
    JAMA; 2017 Nov; 318(20):2004-2010. PubMed ID: 29183075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.